AcelRx Pharma (ACRX) Reports In-Line Q1 EPS

AcelRx Pharma (NASDAQ: ACRX) reported Q1 EPS of ($0.08), in-line with the analyst estimate of ($0.08). Revenue for the quarter came in at $511 thousand versus the consensus estimate of $1.06 million.

For earnings history and earnings-related data on AcelRx Pharma (ACRX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c